Sign in

CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company

Azora Therapeutics, Inc. (DE)

Sign in to watch
Ticker
AZR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
800667150
Phone
434-422-9800
Business address
16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
Former names
ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
  1. 8-K Event Delisting notice
  2. DEF 14A Proxy Proxy Statement
  3. 4 Derivatives Options or other derivatives
  4. 8-K Event Executive or director change
  5. 4 Grant or award Chief Executive Officer acquired 1,000,000 shares (grant or award)
  6. 8-K Event Results of operations
  7. 10-Q Report Quarterly Report
  8. 8-K Event Regulation FD disclosure · Other events
  9. EFFECT Other Notice of Effectiveness
  10. EFFECT Other Notice of Effectiveness
  11. 4 Derivatives Options or other derivatives
  12. 8-K Event Regulation FD disclosure · Other events
  13. POS AM Other Post-effective Amendment for Registration Statement
  14. POS AM Other Post-effective Amendment for Registration Statement
  15. 8-K Event Results of operations
  16. 10-Q Report Quarterly Report
  17. 424B3 Offering Prospectus
  18. EFFECT Other Notice of Effectiveness
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. S-3/A Offering Registration Statement

Page 14 of 30 · 581 filings